1. Home
  2. NERV vs NEN Comparison

NERV vs NEN Comparison

Compare NERV & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.56

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$55.51

Market Cap

197.0M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
NERV
NEN
Founded
2007
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
210.1M
197.0M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
NERV
NEN
Price
$4.56
$55.51
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.50
N/A
AVG Volume (30 Days)
136.4K
487.0
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
2.71%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,175,600.00
$89,196,544.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.68
Revenue Growth
N/A
10.76
52 Week Low
$1.93
$55.61
52 Week High
$12.46
$73.50

Technical Indicators

Market Signals
Indicator
NERV
NEN
Relative Strength Index (RSI) 52.73 40.13
Support Level $3.81 N/A
Resistance Level $4.61 $60.90
Average True Range (ATR) 0.35 0.63
MACD 0.03 -0.07
Stochastic Oscillator 65.79 10.29

Price Performance

Historical Comparison
NERV
NEN

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

Share on Social Networks: